Louis P. Garrison Jr PhD

Louis P. Garrison, Jr., PhD is Professor Emeritus in The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute in the School of Pharmacy, where he joined the faculty in 2004. In October 2016, he became a Senior Visiting Fellow at the Office of Health Economics, London, UK. For the first 13 years of his career, Dr. Garrison worked in non-profit health policy research first at the Battelle Human Affairs Research Centers (Seattle), and then at the Project HOPE Center for Health Affairs (Virginia), where he was the Director from 1989-1992. Following this, he worked as an economist in the pharmaceutical industry for 12 years. From 2002-2004, he was Vice President and Head of Health Economics & Strategic Pricing in Roche Pharmaceuticals, based in Basel, Switzerland.

Dr. Garrison received a BA in Economics from Indiana University and a PhD in Economics from Stanford University. He has more than 150 publications in peer-reviewed journals.

Dr. Garrison was elected as ISPOR President from July 2016 to June 2017. He served on the ISPOR Board of Directors from 2007-09 as well as from 2015-8. He co-chaired two ISPOR Good Practice Task Forces—on Real-World Data and Performance-Based Risk-Sharing Arrangements—and he chaired the ISPOR Health Science Policy Council from 2012 to 2015. He also recently co-chaired the ISPOR Special Task Force on U.S Value Frameworks, and he is the faculty advisor for the UW ISPOR Student Chapter.

He is the immediate past chair of the Past Presidents’ Council and the ISPOR Nominations Committee. He was selected in 2017 by PharmaVOICE as being among “100 of the Most Inspiring People” in the industry. He recently received the PhRMA Foundation and Personalized Medicine Coalition 2018 Value Assessment Challenge First-Prize Award as lead author on a paper on “A Strategy to Support the Efficient Development and Use of Innovations in Personalized and Precision Medicine.”